0362: Interleukin 17 production induced by angiotensin II type 2 receptor activation in T cells drives flow-mediated outward remodeling of mouse resistance arteries  by Caillon, Antoine et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2014) 6, 51-52 51
Topic 24 – Hypertension: Mecanisms – A
0166
Changes in resistance arteries expression of extracellular nucleotides 
signaling partners during arterial hypertension.
Charlotte Roy, Bertrand Toutain, Daniel Henrion, Gilles Kauffenstein
CNRS UMR 6214 – Inserm 1083 BNMI, Angers, France
Cardiovascular diseases are the leading cause of mortality in industrialized 
countries and their prevalence increases with aging populations. Small arteries 
constitute the main site of peripheral vascular resistance and play a key role 
in the regulation of blood pressure. Vascular tone is exacerbated in hyperten-
sion (HBP) and accompanied by a hypertrophy of the arterial wall. Although 
signaling by extracellular nucleotides is important in vascular homeostasis its 
contribution to vascular pathologies affecting small arteries remains poorly 
understood. We evaluated here the expression pattern of nucleotides signaling 
pathway in resistance arteries vs aorta in mice. Genes of interest including P2 
receptors, ectonucleotidases (CD39, CD73) and hemi channels (connexins, 
pannexins) were investigated by quantitative RT-PCR. Their expression in 
resistance arteries was assessed in Angiotensin II-treated mice, spontaneously 
hypertensive rats (SHR) and, since HBP is related to age, in 24-month old 
mice. Our results showed that several genes are more expressed in aorta 
(P2ry2 and connexin 43) while others are expressed specifically (P2rx1, 
connexin 37) or preferentially (P2ry6) in small arteries. The latest might be 
involved in pathologies affecting the small arteries. With HBP, we observed a 
decreased connexin 37 and 40 expression level in Angiotensin II-treated mice 
and in SHR respectively and both decreased with aging. Interestingly, CD39 
(tone regulator) decreased in the two models of HBP and with aging. Such 
decrease in nucleotidase activity may enhance P2 receptors activation and 
increase vascular contractility/tone. This is especially true considering P2Y6 
(tone promoter) that increased with aging. Further studies may allow us to 
evaluate the contribution of these mediators in the development of small 
arteries defect in aging associated or not with HBP. Signaling by extracellular 
nucleotides may constitute new therapeutic targets in the treatment of HBP.
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Deficiency in nitric oxide decreases the microcirculation reactivity in 
response to acetylcholine but is not always associated with a higher 
blood pressure in mice
Marc Isabelle, Sébastien Taupe, Stefano Chimenti, Nicole Villeneuve, 
Jean-Paul Vilaine
Institut de recherches Servier, Recherches cardiovasculaire, Suresnes, 
France
Endothelial dysfunction is associated with cardiovascular diseases and can 
be evaluated in clinical setting for risk stratification in patients. Flow mediated 
dilation (FMD) or local acetylcholine (ACh) administration are used to assess 
endothelial dysfunction in arteries but also in microcirculation (MC) using 
Laser Doppler Flowmetry (LDF). In our study, we aim to investigate the role 
of nitric oxide (NO) in the endothelial response of microcirculation in vivo in 
mice. Two strains of mice (C57BL6 and BALBc mice; 20 weeks old) were 
treated with NO synthase inhibitor (L-NAME) in drinking water (1 g/L) and 
compared with their respective untreated controls. After 3 or 7 days of L-
NAME, mice were anesthetized with isoflurane. Systolic blood pressure (SBP) 
was then measured by plethysmography and skin MC assessed by LDF. Blood 
flow was measured at baseline and in response to ACh administered by ionto-
phoresis or during hyperemic response due to local heating at 44°C. At day 3, 
we observed a slight increase in SBP only in BALBc mice treated with L-
NAME (+13 mmHg), not maintained at day 7. Conversely, at day 7, we 
observed an increase in SBP (+30 mmHg) only in L-NAME-treated C57BL6 
mice. MC flow response to ACh was decreased by 65% and 58% in BALBc 
mice at day 3 and 7, respectively, and by 68% in C57BL6 mice only after 
7 days of L-NAME treatment compared to untreated mice. No difference was 
observed in response to local heating, neither between strains nor after L-
NAME treatment. In conclusion, skin microcirculation reactivity can be rou-
tinely assessed in vivo in mice. Our results show that a part of the transitory 
Ach-induced microcirculation flow increase is NO-mediated. Moreover, this 
decrease in NO bioavailability in microcirculation is not always associated 
with increase in systemic BP. Further studies are now required in order to 
determine if the microcirculation response to ACh could be a marker of coro-
nary endothelial function in animal models as it is in human.
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Role of kinins in diabetic wound healing
Dorinne Desposito, Catherine Chollet, Christopher Taveau, Ronan Rous-
sel, Francois Alhenc-Gelas, Nadine Bouby, Ludovic Waeckel
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The diabetic foot is associated with pain, decrease in patient’s quality of life, 
considerable costs, and amputation. In this study, we determined the role of KKS, 
via activation of bradykinin receptors (B1R or B2R), in a mouse model of dia-
betic wound healing. Diabetic or nondiabetic mice are wounded with an 8-mm 
punch biopsy and then are treated or not with specific B1R or B2R agonists 
(720nmol/kg.d-1) and/or B2R antagonist (Icatibant, 500μg/kg.d-1). The wound-
healing surface was daily followed up. At 11 days, the scar were analysed by his-
tology (Masson’s trichrome staining) and B1R and B2R expression were assessed 
(RT-qPCR). Effects of the agonists on cells (fibroblasts and keratinocytes) migra-
tion and proliferation were also analysed. In diabetic condition, mRNA of B1R 
and B2R was increased in skin (p<0.01). B1R activation had no effect on wound 
closure in our model. In contrast, B2R activation dramatically delayed wound 
healing in diabetic (p<0.001) or nondiabetic (p<0.01) mice. Histological analysis 
of scar showed significant skin disorganization and epidermis thickening with 
B2R agonist (p<0.05). In vitro, B2R agonist induced an increase of keratinocyte 
proliferation (+46% after 48h, p<0.01) and a stimulation of keratinocyte migration 
(+30% after 24h, p<0.05). These effects was associated with ERK phosphoryla-
tion which occurs downstream of EGFR activation (p<0.05). B2R agonist had no 
effect on fibroblast migration but decreased fibroblast proliferation (–33% after 
48h, p<0.05). Co-treatment with Icatibant abrogated in vivo and in vitro effects 
observed with B2R agonist. Moreover, Icatibant alone hastened wound healing 
and decrease the epidermis thickening induced by diabetes. In conclusion, KKS, 
through the B2R but not the B1R, plays a critical role in proliferation and remod-
elling phases of skin wound healing in mice. While more studies are needed, Ica-
tibant could be used to correct the diabetic wound healing defect.
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Objective: Flow (shear stress)-mediated outward remodeling of resistance 
arteries is involved in collateral growth during postischemic revascularization. 
Besides the NO pathway the involvement of inflammatory factors and reactive 
oxygen species has been suggested in this remodeling although the mechanism 
and the sequence remains unknown. As T cells drive the inflammatory 
response, we investigated their role in flow-mediated remodeling. Mouse mes-
enteric resistance arteries (250μm internal diameter) were submitted in vivo to 
a chronic increase (144±18 to 239±25 μl/min) in blood flow. Arteries were 
collected for in vitro analysis after 1 to 7 days.
Results: After 1 week, remodeling occurred in high flow (HF) arteries 
(diameter increased from 242±21μm to 324±20μm, n=xx per group, P<00.1) 
in control mice. No remodeling occurred in nude mice and in mice treated 
with anti-CD3 antibodies. In control arteries lymphocyte T cells accumulate 
around HF arteries at day 1 (shown using both immunohistology and flow 
cytometry) and they expressed angiotensin II type 2 receptor (AT2R). In iso-
lated T cells AT2R stimulation induced preferentially IL-17 production 
(20±6pg/ml to 50±5pg/ml, n=xx per group, P<00.1). We then tested the occur-
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rence of remodeling in mice lacking AT2R or IL-17. In both AT2R-/- and IL-
17-/- mice diameter expansion did not occur whereas T cells and myeloid cells 
accumulation around the HF artery was not affected. IL-17 infusion (5ng/h, 
Alzet osmotic minipump) to nude mice and to AT2R-/- mice restored HF 
remodeling to control level. In order to confirm the role of AT2R in flow-
mediated remodeling in another vascular territory, neovascularization was 
examined using an ischemic skin flap model in AT2R-/- mice. As in mesen-
teric arteries, the absence of AT2R prevented diameter expansion in the 
arteries feeding the skin flap.
Conclusion: we demonstrate for the first time the involvement of lympho-
cytes T cells polarization into TH17 by angiotensin II type 2 receptor in flow-
mediated outward remodeling of resistance arteries.
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Role of vascular mineralocorticoid receptor in renal injury induced 
by ischemia/reperfusion
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Introduction: Acute kidney injury (AKI) is defined as an abrupt decrease 
(48h) in kidney function. One of the main causes of AKI is ischemia/reperfusion 
(I/R). AKI is related with high mortality, chronic kidney disease development 
and cardiac alterations like heart failure and arrhythmias. Mineralocorticoid 
receptor (MR) antagonism with spironolactone (Sp) prevents tubular injury and 
renal dysfunction induced by I/R in the rat. Although there is information sup-
porting a role for aldosterone and MR in kidney injury, it remains unexplored the 
specific role of the MR expressed in the vasculature in mediating the deleterious 
effects of aldosterone during renal I/R.
Objective: To study the effect of inducing I/R in mice lacking the MR spe-
cifically in the endothelial cells or in the vascular smooth muscle cells.
Methods: To test if Sp is also able to prevent renal injury induced by I/R 
in the mice with the C57BL/6 background (same as MR KO mice) we 
included three groups of mice: 1) Sham, 2) I/R 20 min and 3) I/R 20 min + 
Sp pre-treatment. We analyzed the presence of renal dysfunction and inflam-
matory cytokines. In the MR KO mice, we will analyze the effect of MR defi-
ciency after renal I/R in an acute phase (24h) and in chronic kidney disease 
development (after 4 weeks). In the acute studies the mechanisms that will be 
explored include: polarization of macrophages, endothelial injury and oxida-
tive stress. In the chronic studies we will test if the wild type or MR knockout 
mice develop CKD as a consequence of renal I/R.
Results: Mice underwent renal I/R developed injury characterized by 
increased serum creatinine and urea levels, urinary Hsp72 and elevation in the 
mRNA of TNF-alpha and MCP-1 pro-inflammatory cytokines. These altera-
tions were prevented by the Sp pre-treatment.
Conclusion: The protective effect of Sp against renal I/R that was previ-
ously reported in the rat is also observed in the C57BL/6 mice and supports 
the study of the MR KO mice in the renal I/R setting.
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Introduction: Cyclosporine-induced Nephrotoxicity (CIN) is a major 
adverse event but its pathophysiology remains unclear. Mineralocorticoid 
Receptor (MR) pharmacological antagonism prevents CIN in rats by modu-
lating the expression of vasoactive factors. Our team has shown that MR is 
expressed in endothelial and vascular smooth muscle cells (VSMC). There-
fore, genetic MR manipulations in endothelium or VSMC modify vascular 
function. Our working hypothesis is that vascular MR activation plays a key 
role in CIN.
Methods: Female mice with low-salt diet were used: 1) Pharmacological 
approach: Control (Vehicle), Cyclosporine-A (CsA, 100mg/kg/d) and CsA + 
Can (CsA + Canrenoate 30mg/kg/d, MR antagonist); 2) Genetic approach: 
MR KO in VSMC (MRKO-VSMC) or in Endothelial Cells (MRKO-EC) 
treated or not with CsA.
Results: Body weight loss is greater in Cyclosporine-treated groups 
(p<0.05). Renal function is impaired (p<0.05) and CsA induces renal histolog-
ical damages that are prevented by MR antagonism or by MR KO in VSMC 
but not in endothelial cells. Canrenoate and MR KO in VSMC also prevent 
Cyclosporine-induced renal expression (mRNA) of NGAL (Neutrophil Gela-
tinase Associated Lipocalin), a kidney damage marker. CsA induced NGAL 
expression in proximal tubules (immunohistochemistry); this effect is pre-
vented by MR antagonism and MR KO in VSMC but not in endothelial cells.
Conclusions: We show that MR antagonism has beneficial effect on 
Cyclosporine-induced renal damages that, at least partially, involve VSMC 
MR. The underlying cellular mechanisms are currently under investigation. A 
clinical trial testing the safety of MR antagonism (Eplerenone) in renal trans-
plant recipients treated with Cyclosporine is currently ongoing.
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pressure overload involve microenvironment inflammation
Dounia Abbadi (1), Fanny Laroumanie (1), Anne-Catherine Prats (2), 
Angelo Parini (1), Nathalie Pizzinat (1)
(1) I2MC, Toulouse, France – (2) Tradgene UPS EA4554, Toulouse, 
France
Backgrounds: Tenascin-C (TN-C) is an extracellular matrix glycoprotein 
slightly presented in adult tissue but transiently expressed upon tissue injury. 
It is a well-known regulator of multiple cellular functions during embryogen-
esis, wound healing and cancer. Several studies suggest a potential role of 
inflammation induced by the expression of Danger Associated Molecular Pat-
terns (DAMPs) in the development of heart failure. These molecules are able 
to synthesize pro-inflammatory cytokines through Toll Like Receptors 
(TLRs). TN-C is considered as a DAMP through its property to induce the 
expression of pro-inflammatory cytokines via TLR4. Moreover, its expression 
is increased in various cardiac diseases. Here, we investigate the role of TN-C 
on cardiac remodeling induced by pressure overload as well as its impact on 
cardiac fibroblasts and bone marrow derived macrophages.
Methods and results: C57BL/6 mice WT and KO for TN-C were sacrified 
6 weeks after a transverse aortic constriction (TAC). Echocardiographic mea-
surements showed that KO mice did not exhibit an increased size of the left 
ventricular cavity and had a better fractional shortening compared to WT mice 
after TAC. The deletion of TN-C prevented pro-inflammatory environment 
and attenuated fibrosis. To better understand the role of TN-C, cardiac fibro-
blasts were transduced by a lentivector expressing GFP or TN-C. TN-C pro-
duction by fibroblasts stimulated their expression of pro-inflammatory 
cytokines and chemokines like TNFα or CCL2. Moreover TN-C increased 
phagocytic activity of bone marrow derived macrophages and nitrite release in 
the supernatant suggesting a pro-inflammatory macrophages polarization by 
TN-C.
Conclusions: TN-C seems to have a deleterious effect on cardiac remo-
deling. It also induces expression of pro-inflammatory genes in cardiac fibro-
blasts as well as pro-inflammatory macrophages polarization. Further studies 
are required to better understand the exact role of this protein in heart failure.
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